OLON, INTERNATIONAL API SUPPLIER, RELEASES THE NEW SUSTAINABILITY REPORT 2022 CONFIRMING THE PROGRESS OF ITS SUSTAINABILITY IN THE FOCUS AREAS
PR98899
OLON, INTERNATIONAL API SUPPLIER, RELEASES THE NEW SUSTAINABILITY REPORT 2022 CONFIRMING THE PROGRESS OF ITS SUSTAINABILITY IN THE FOCUS AREAS OF ENVIRONMENT, SUPPLY CHAIN, PEOPLE, COMMUNITY ENGAGEMENT, PRODUCTION
MILAN, Nov. 21, 2022 /PRNewswire=KYODO JBN/ --
"Our ambition is to promote a more sustainable production of APIs, meeting the
highest standards of quality" Paolo Tubertini, CEO of the Group, commented "To
achieve this, we are investing in people, in innovation and technology
processes, endorsing the sustainable development goals proposed by the UN 2030
Agenda"
Olon, international API supplier, is proud to publish the annual Corporate
Sustainability Report for 2022, which details the global company commitment to
people, planet, and communities in which it operates. The report outlines the
substantial progresses achieved in the focus areas - to reduce the footprint on
the environment, to create a sustainable global supply chain, to include people
diversity, to engage communities and stakeholder, to promote the most advanced
and sustainable manufacturing processes.
"After the 2021 publication of our first Sustainability Manifesto, this is a
clear statement and policy document representing that we are pursuing our
vision of sustainable growth. It is an assumption of responsibility towards
customers, partners, and employees. Our vision is to be a global leader in API
production from a business, social and ethical perspective. We will continue to
introduce new initiatives to deliver our future ambitions" Paolo Tubertini
commented
The full report here: https://olonspa.com/we-are-olon#sustainability
Olon Group is a global leader in the development and production of active
pharmaceutical ingredients for CDMO and Generics, a reliable and preferential
partner to the pharmaceutical, biotech, and specialty ingredients markets. With
a 2021's turnover of 580 Mio$, OLON supplies 300 APIs for the Generic market.
Thanks to all the 2.300 employees, and to highly qualified R&D team – more than
300 people – OLON can offer complete integrated packages and services to
support the full development of APIs based on strong knowledge in both Chemical
and Biological process, all of them under a full cGMP and regulatory coverage –
holder of about 160 active US DMFs and 79 granted CoS.
Headquartered in Rodano (Milan, Italy), OLON has 11 manufacturing facilities -
8 located in Italy, 1 in Spain, 1 in USA and 1 in India, designed in compliance
with the strictest international requirements, and 3 branch offices in Hamburg
(Germany), Florham Park NJ (USA) and Shanghai (China).
PDF - https://mma.prnewswire.com/media/1951610/OLON_GROUP.pdf
Logo - https://mma.prnewswire.com/media/1909743/Olon_SpA_logo.jpg
Source: OLON S.p.A.
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。